PL2802209T3 - Preparaty do uszu - Google Patents
Preparaty do uszuInfo
- Publication number
- PL2802209T3 PL2802209T3 PL13735820T PL13735820T PL2802209T3 PL 2802209 T3 PL2802209 T3 PL 2802209T3 PL 13735820 T PL13735820 T PL 13735820T PL 13735820 T PL13735820 T PL 13735820T PL 2802209 T3 PL2802209 T3 PL 2802209T3
- Authority
- PL
- Poland
- Prior art keywords
- otic formulations
- otic
- formulations
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F11/00—Methods or devices for treatment of the ears or hearing sense; Non-electric hearing aids; Methods or devices for enabling ear patients to achieve auditory perception through physiological senses other than hearing sense; Protective devices for the ears, carried on the body or in the hand
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Acoustics & Sound (AREA)
- Biophysics (AREA)
- Otolaryngology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261585031P | 2012-01-10 | 2012-01-10 | |
| US201261625407P | 2012-04-17 | 2012-04-17 | |
| US201261649663P | 2012-05-21 | 2012-05-21 | |
| PCT/US2013/020152 WO2013106230A1 (en) | 2012-01-10 | 2013-01-03 | Otic formulations, methods and devices |
| EP13735820.6A EP2802209B1 (en) | 2012-01-10 | 2013-01-03 | Otic formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2802209T3 true PL2802209T3 (pl) | 2021-07-05 |
Family
ID=48744403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13735820T PL2802209T3 (pl) | 2012-01-10 | 2013-01-03 | Preparaty do uszu |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8945061B2 (pl) |
| EP (1) | EP2802209B1 (pl) |
| AU (1) | AU2013208252B2 (pl) |
| CA (1) | CA2862406C (pl) |
| ES (1) | ES2845948T3 (pl) |
| PL (1) | PL2802209T3 (pl) |
| WO (1) | WO2013106230A1 (pl) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8318817B2 (en) | 2008-07-21 | 2012-11-27 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| CA2862406C (en) | 2012-01-10 | 2024-06-18 | Entrx LLC | Otic formulations, methods and devices |
| US9078853B2 (en) * | 2013-06-18 | 2015-07-14 | Cmpd Licensing, Llc | Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders |
| US20160175323A1 (en) * | 2013-07-22 | 2016-06-23 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical compositions for intraocular administration and methods for fabricating thereof |
| US20160101118A1 (en) * | 2014-08-15 | 2016-04-14 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical compositions for intraocular administration and methods for fabricating thereof |
| US20160279055A1 (en) * | 2013-07-22 | 2016-09-29 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof |
| US20150164882A1 (en) | 2013-07-22 | 2015-06-18 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical compositions for intraocular administration and methods for fabricating thereof |
| US20150025511A1 (en) * | 2013-07-22 | 2015-01-22 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical compositions for intraocular administration and methods for fabricating thereof |
| US20150045739A1 (en) * | 2013-08-12 | 2015-02-12 | Novartis Ag | Method for treating otic infections after tympanostomy tube placement |
| US9814673B2 (en) * | 2014-08-12 | 2017-11-14 | Imprimis Pharmaceuticals, Inc. | Intraocular lens comprising pharmaceutical compositions and methods for fabricating thereof |
| US11684567B2 (en) | 2015-08-05 | 2023-06-27 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
| US20190167527A1 (en) * | 2015-08-05 | 2019-06-06 | Cmpd Licensing, Llc | Topical antimicrobial compositions and methods of formulating the same |
| US11446236B2 (en) | 2015-08-05 | 2022-09-20 | Cmpd Licensing, Llc | Topical antimicrobial compositions and methods of formulating the same |
| US11793783B2 (en) | 2015-08-05 | 2023-10-24 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
| WO2017100576A1 (en) * | 2015-12-11 | 2017-06-15 | Otonomy, Inc. | Ciprofloxacin otic composition and kits and method for using same |
| US10610513B2 (en) * | 2016-01-11 | 2020-04-07 | Klox Technologies Limited | Biophotonic compositions for the treatment of otitis externa |
| WO2018053173A1 (en) * | 2016-09-16 | 2018-03-22 | Otonomy, Inc. | Otic gel formulations for treating otitis externa |
| RU2642617C1 (ru) * | 2017-02-01 | 2018-01-25 | Александр Анатольевич Хахалин | Комплексный препарат для лечения острых и хронических отитов паразитарного, бактериального и грибкового происхождения у собак, кошек, пушных зверей и кроликов |
| KR101961551B1 (ko) | 2017-06-09 | 2019-03-25 | 서울대학교산학협력단 | 외이도 치료용 약액 전달 장치 |
| IT201900005280A1 (it) * | 2019-04-05 | 2020-10-05 | Ntc S R L | Composizione otologica |
| CN120284977A (zh) | 2019-10-11 | 2025-07-11 | 德克拉兽医产品公司 | 耳用制剂、方法和装置 |
| EP4203958A4 (en) * | 2020-08-26 | 2024-10-09 | Oticara, Inc. | COMPOSITIONS, DEVICES AND METHODS FOR TREATING NOSE, EAR AND OTHER TISSUE INFECTIONS AND/OR INFECTIONS |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6509327B1 (en) * | 1998-09-30 | 2003-01-21 | Alcon Manufacturing, Ltd. | Compositions and methods for treating otic, ophthalmic and nasal infections |
| US7220431B2 (en) | 2002-11-27 | 2007-05-22 | Regents Of The University Of Minnesota | Methods and compositions for applying pharmacologic agents to the ear |
| US20070078116A1 (en) * | 2003-08-20 | 2007-04-05 | Fairfield Clinical Trials, Llc | Method of treatment of otitis externa |
| US7618651B2 (en) * | 2004-06-24 | 2009-11-17 | Idexx Laboratories | Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same |
| DE102005055385A1 (de) * | 2004-12-09 | 2006-06-14 | Bayer Healthcare Ag | Arzneimittel zur hygienischen Applikation im Ohr |
| US8337481B2 (en) * | 2005-01-25 | 2012-12-25 | Patrick Slater | Method for treating otitis externa |
| WO2006081327A2 (en) * | 2005-01-25 | 2006-08-03 | University Of Vermont And State Agricultural College | Small molecules that reduce fungal growth |
| US20090082337A1 (en) * | 2007-09-21 | 2009-03-26 | Srini Venkastesh | Compositions Comprising Quinolone and Methods for Treating or Controlling Infections |
| WO2009139924A2 (en) | 2008-05-14 | 2009-11-19 | Otonomy, Inc. | Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
| TW201010708A (en) * | 2008-06-02 | 2010-03-16 | Intervet Int Bv | Composition comprising an antibiotic and a corticosteroid |
| US8318817B2 (en) * | 2008-07-21 | 2012-11-27 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| CA2862406C (en) | 2012-01-10 | 2024-06-18 | Entrx LLC | Otic formulations, methods and devices |
-
2013
- 2013-01-03 CA CA2862406A patent/CA2862406C/en active Active
- 2013-01-03 AU AU2013208252A patent/AU2013208252B2/en active Active
- 2013-01-03 WO PCT/US2013/020152 patent/WO2013106230A1/en not_active Ceased
- 2013-01-03 US US13/733,727 patent/US8945061B2/en active Active
- 2013-01-03 EP EP13735820.6A patent/EP2802209B1/en active Active
- 2013-01-03 ES ES13735820T patent/ES2845948T3/es active Active
- 2013-01-03 PL PL13735820T patent/PL2802209T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2802209B1 (en) | 2020-12-02 |
| EP2802209A1 (en) | 2014-11-19 |
| US8945061B2 (en) | 2015-02-03 |
| EP2802209A4 (en) | 2015-08-05 |
| US20130178801A1 (en) | 2013-07-11 |
| AU2013208252A1 (en) | 2014-07-03 |
| WO2013106230A1 (en) | 2013-07-18 |
| CA2862406A1 (en) | 2013-07-18 |
| CA2862406C (en) | 2024-06-18 |
| ES2845948T3 (es) | 2021-07-28 |
| AU2013208252B2 (en) | 2016-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2802209T3 (pl) | Preparaty do uszu | |
| SI3117837T1 (sl) | Formulacije protiteles | |
| EP2889490A4 (en) | FAN | |
| GB2506426B (en) | Composition | |
| PL2804487T3 (pl) | Kompozycja | |
| ZA201500519B (en) | Composition | |
| EP2878295A4 (en) | COMPOSITION | |
| GB2498803B (en) | Composition | |
| GB201218954D0 (en) | Composition | |
| GB2508825B (en) | Composition | |
| GB201201287D0 (en) | Compositions | |
| HRP20190326T1 (hr) | Pripravak | |
| GB201206035D0 (en) | Composition | |
| ZA201407419B (en) | Composition | |
| IL236357A0 (en) | The composition of misoprostol | |
| EP2910537A4 (en) | AGENT COMPOSITION GENERATING GAS | |
| GB201218195D0 (en) | Composition | |
| GB201209597D0 (en) | Composition | |
| GB201208133D0 (en) | Composition | |
| GB201311517D0 (en) | Composition | |
| GB201219383D0 (en) | Composition | |
| SG11201405751TA (en) | Composition | |
| GB201206178D0 (en) | Formulations | |
| EP2926813A4 (en) | METFORMIN-Orlistat COMPOSITIONS | |
| GB201223526D0 (en) | Composition |